相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance
Zahra Zandi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)
Endometrial cancer
Emma J. Crosbie et al.
LANCET (2022)
DUSP4 Silencing Enhances the Sensitivity of Breast Cancer Cells to Doxorubicin through the Activation of the JNK/c-Jun Signalling Pathway
Mashael S. Al-Mutairi et al.
MOLECULES (2022)
Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response
Jayaprakash Mandal et al.
JOURNAL OF BIOMEDICAL SCIENCE (2022)
Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma
Feng-Kun Zhang et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
PKCδ mediates mitochondrial ROS generation and oxidation of HSP60 to relieve RKIP inhibition on MAPK pathway for HCC progression
Jaya Prakash Mandal et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990?2019
Baoxia Gu et al.
GYNECOLOGIC ONCOLOGY (2021)
Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers
Takahiro Ito et al.
NATURE GENETICS (2021)
Loss of DUSP4 Expression as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
Seongsik Bang et al.
DIAGNOSTICS (2021)
A novel human endometrial epithelial cell line for modeling gynecological diseases and for drug screening
Youngran Park et al.
LABORATORY INVESTIGATION (2021)
Low DUSP4 Expression Is Associated With Aggressive Phenotypes and Poor Prognosis in Gastric Cancer
Seongsik Bang et al.
IN VIVO (2021)
Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer
Ting-Tai Yen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2020)
Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming
Yohan Suryo Rahmanto et al.
NATURE COMMUNICATIONS (2020)
Effect and biomarker of immune checkpoint blockade therapy for ARID1A deficiency cancers
Li Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Identification of the Mutational Landscape of Gynecological Malignancies
Suresh Chava et al.
JOURNAL OF CANCER (2020)
Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
Hideaki Ogiwara et al.
CANCER CELL (2019)
miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4
Feiya Du et al.
CELL DEATH & DISEASE (2019)
Racial disparities in molecular subtypes of endometrial cancer
Elizabeth A. Dubil et al.
GYNECOLOGIC ONCOLOGY (2018)
The Tumor Suppressor ARID1A Controls Global Transcription via Pausing of RNA Polymerase II
Marco Trizzino et al.
CELL REPORTS (2018)
Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway
Rui Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers
Timothy W R Kelso et al.
eLife (2017)
ARID1A gene mutation in ovarian and endometrial cancers
Takashi Takeda et al.
ONCOLOGY REPORTS (2016)
Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells
Yohan Suryo Rahmanto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
Benjamin G. Bitler et al.
NATURE MEDICINE (2015)
Defining optimal combinations of PI3K/Akt/mTOR and Ras/Raf/MAPK pathway inhibitors for use in endometrial cancer
S.S. Isani et al.
GYNECOLOGIC ONCOLOGY (2014)
Roles of Deletion of Arid1a, a Tumor Suppressor, in Mouse Ovarian Tumorigenesis
Bin Guan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
Loss of ARID1A Expression Correlates With Stages of Tumor Progression in Uterine Endometrioid Carcinoma
Tsui-Lien Mao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
Ruth Perets et al.
CANCER CELL (2013)
Activation of MAPK Pathways due to DUSP4 Loss Promotes Cancer Stem Cell-like Phenotypes in Basal-like Breast Cancer
Justin M. Balko et al.
CANCER RESEARCH (2013)
Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin
Yu Liu et al.
EXPERIMENTAL CELL RESEARCH (2013)
ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas
Eleftherios P. Samartzis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
Cigall Kadoch et al.
NATURE GENETICS (2013)
Decreased expression of DUSP4 is associated with liver and lung metastases in colorectal cancer
Susumu Saigusa et al.
MEDICAL ONCOLOGY (2013)
ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor?
Jennifer N. Wu et al.
CANCER DISCOVERY (2013)
ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
Bin Guan et al.
CANCER RESEARCH (2011)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Dual-specificity phosphatases: critical regulators with diverse cellular targets
Kate I. Patterson et al.
BIOCHEMICAL JOURNAL (2009)
Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma
Bozena Dobrzycka et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2009)
Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses
Kate L. Jeffrey et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Chromatin remodeling and cancer, part II: ATP-dependent chromatin remodeling
Gang G. Wang et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Diverse physiological functions for dual-specificity MAP kinase phosphatases
Robin J. Dickinson et al.
JOURNAL OF CELL SCIENCE (2006)
Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo
M Groszer et al.
SCIENCE (2001)